Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@medstudentinvst Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1948243155779792896.png) @medstudentinvst WaveStrum Life Sciences

WaveStrum Life Sciences posts on X about $nktr, $vktx, $pepg, $rna the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1948243155779792896/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1948243155779792896/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +94%

### Mentions: X [#](/creator/twitter::1948243155779792896/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1948243155779792896/c:line/m:posts_active.svg)

- X Week XX -XXXX%
- X Month XX +31%

### Followers: XXX [#](/creator/twitter::1948243155779792896/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1948243155779792896/c:line/m:followers.svg)

- X Week XXX +6.20%
- X Month XXX +171%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1948243155779792896/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1948243155779792896/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1948243155779792896/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXXX% [stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX% [currencies](/list/currencies)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[$nktr](/topic/$nktr) 12.5%, [$vktx](/topic/$vktx) 12.5%, [$pepg](/topic/$pepg) 9.38%, [$rna](/topic/$rna) 9.38%, [$beam](/topic/$beam) 9.38%, [$prme](/topic/$prme) 9.38%, [alltime](/topic/alltime) 9.38%, [$pcvx](/topic/$pcvx) #1, [$ntla](/topic/$ntla) 6.25%, [bitcoin](/topic/bitcoin) XXXX%

**Top accounts mentioned or mentioned by**
[@stocksdd](/creator/undefined) [@darrenestes](/creator/undefined) [@geneinvesting](/creator/undefined) [@adambliv](/creator/undefined) [@spcas9point5](/creator/undefined) [@javier944712106](/creator/undefined) [@pikabulb](/creator/undefined) [@andrews87261985](/creator/undefined)

**Top assets mentioned**
[Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [BEAM (BEAM)](/topic/$beam) [Vaxcyte, Inc. Common Stock (PCVX)](/topic/$pcvx) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Bitcoin (BTC)](/topic/bitcoin) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Public Service Enterprise Group, Inc. (PEG)](/topic/$peg) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Sable Offshore Corp. (SOC)](/topic/$soc) [Thermo Fisher Scientific Inc. (TMO)](/topic/$tmo) [SuperRare (RARE)](/topic/$rare)
### Top Social Posts [#](/creator/twitter::1948243155779792896/posts)
---
Top posts by engagements in the last XX hours

"Hypothesis for a contributor to $PEPG s differentiated splicing improvement in DM1. $RNA and $DYN use DMPK1 RNA silencers which degrade and destroy the DMPK mRNA. In contrast $PEPG s ASO binds to the CUG repeats and sterically blocks the hairpin loop formation allowing the DMPK mRNA transcript to be translated normally. Most biological systems have negative feedback loops. So an increase in expression production or activity or a molecule will trigger inhibition of the expression production or activity of that molecule. Given $PEPG allows the DMPK mRNA to operate normally and produce the DMPK"  
[X Link](https://x.com/medstudentinvst/status/1974397895387292146) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-04T08:55Z XXX followers, 1682 engagements


"October 10th 2025 Daily Update I allocated the remaining $RNA cash to $JANX today. If $NKTR continues to move down I will likely exit the tiny $BEAM and $VKTX holdings and put those towards $NKTR. Portfolio as a whole drew back about XXX% today largely driven by the top X positions in the portfolio ( $PRME $NTLA $PEPG). I expect $PRME and $PEPG to continue to experience significant volatility over the short to medium term and consider these price movements irrelevant unless my long-term thesis on the business changes or new data emerges. Though it means the portfolio as a whole is likely to"  
[X Link](https://x.com/medstudentinvst/status/1976791208090353940) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-10T23:25Z XXX followers, 2486 engagements


"October 8th 2025 Daily Update All-time high. $NTLA and $PRME with big days. Though I would not be surprised to see continued volatility and a retraction. The gains for $NTLA are really little more than just noise until the data readouts in a few weeks. As mentioned in a previous post I exited $RNA at an effectively flat valuation. This is largely a function of believing there are biotech companies with similar risk profiles that have a higher upside rather than a negative view of $RNA. Certainly could be bought out and there is likely upside there. I initially entered $RNA as a relatively"  
[X Link](https://x.com/medstudentinvst/status/1976018897498255644) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-08T20:16Z XXX followers, XXX engagements


"$ABVX didn't update again and just realized so here is the corrected daily update for $ABVX's actual close price. No change to headline total return"  
[X Link](https://x.com/medstudentinvst/status/1976020094007275595) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-08T20:21Z XXX followers, XXX engagements


"Just closed small remaining positions in $VKTX and $BEAM. Proceeds went into $NKTR. Portfolio weights will be updated in daily update tonight"  
[X Link](https://x.com/medstudentinvst/status/1978472233396732196) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T14:45Z XXX followers, XXX engagements


"Mostly just wanted to put the cash towards $NKTR. My view on $VKTX continue to be it likely has a market and upside if it maintains headline efficacy lead in the GLP-1 / GIP agonist class regardless of any side-effect incidence matched comparisons though competition from big players is intense and CMC remains important. I think it's likely continue to show in upcoming data readouts"  
[X Link](https://x.com/medstudentinvst/status/1978474237909176407) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T14:53Z XXX followers, XXX engagements


"@AdamBLiv Alternatively you could just buy an asset that has a XXX% CAGR. Neither a 401k nor bitcoin necessary. I am the quant now"  
[X Link](https://x.com/medstudentinvst/status/1978524731780345899) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T18:13Z XXX followers, XX engagements


"Alternatively you could just buy an asset that has a XXX% CAGR. Neither a 401k nor bitcoin necessary. I am the quant now"  
[X Link](https://x.com/medstudentinvst/status/1978524780434255958) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T18:14Z XXX followers, XXX engagements


"Early Daily Update for posterity as I might never see this again and this whole thing could easily collapse tomorrow. The current portfolio is all green. The big glaring red mark is that dumb throwaway $MGX position I exited. The intrusive thoughts to re-enter and try and ride it until I erase that -XXXX% are flying simply fast and furious rn"  
[X Link](https://x.com/medstudentinvst/status/1978540347014946998) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T19:15Z XXX followers, XXX engagements


"Wednesday October 15th 2025 Daily Update All-time high. Though always needs to be said this is a high risk portfolio and there are a number of upcoming events that could turn the ship right around. As mentioned closed the very small $BEAM and $VKTX positions today and put virtually all remaining cash into $NKTR"  
[X Link](https://x.com/medstudentinvst/status/1978553595974033891) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T20:08Z XXX followers, 1016 engagements


"I have seen a number of posts questioning the safety of $PEPG's DM1 therapy based on previously published results for $PEPG's DMD therapy. I think there are a few misunderstandings regarding safety that are important to clear up. For background $PEG 's EDO-DM1 treats Myotonic Dystrophy Type X. EDO-51 treated DMD XX. These are two very different genetic diseases and both the structure and functional objective of each therapy's ASO is correspondingly very different. First $PEPG's EDO-51 DMD program was terminated by PEPGEN for efficacy not for safety. The mean increase in dystrophin expression"  
[X Link](https://x.com/medstudentinvst/status/1973020486834507891) [@medstudentinvst](/creator/x/medstudentinvst) 2025-09-30T13:41Z XXX followers, 3633 engagements


"$ALNY has returned 76.5x since inception. $10000 invested at $X would be $766500 today. $50000 would be $3.83M today. $100000 would be $7.66M The picture attached is $ALNY 's stock chart. This represents the argument for why to stay long in the face of volatility when invested in early stage biotechnology companies which you believe have a very good chance of seeing enormous value accretion over the long-term based on TAM competitive differentiation current valuation etc. $ALNY 's share price saw significant volatility over the years. It collapsed soared plateaued and everything in between."  
[X Link](https://x.com/medstudentinvst/status/1975685770737258774) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-07T22:12Z XXX followers, 1494 engagements


"Lorenzo "Botswana" (who has $1Bn of AUM a PhD XX other acronyms and clips $20M of annual management fees given he obviously is a X and XX guy minimum) shorted $SOC at $XX as announced after the fact. Word is he was also long $SPRB as announced the day after it increased XX trillion percent. Are there any investor materials available for a highly interested prospective LP such as myself"  
[X Link](https://x.com/medstudentinvst/status/1978494913189703975) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T16:15Z XXX followers, 4624 engagements


"September 30th 2025 Daily Update This can't continue forever. but another all-time high today largely on the strength of $PRME. Good to see $PCVX back in the green too after announcing a $1Bn manufacturing deal with Thermo Fisher. My sense is $PCVX will be a beneficiary of a couple things: X. The market's realization that NIH / FDA isn't anti-vaccine it's anti-stupid vaccine. Or said more academically it's anti-vaccine for vaccines that have an unclear risk-reward tradeoff. In the United States pneumococcal pneumonia is estimated to result in approximately 150000 hospitalizations each year"  
[X Link](https://x.com/medstudentinvst/status/1973174061921357930) [@medstudentinvst](/creator/x/medstudentinvst) 2025-09-30T23:52Z XXX followers, 1076 engagements


"$PCVX continues to inch-up. They still have data to show of course. However in my personal view it was an absolute steal a steal to be able to get this in the 30's for a company as large it is with such a strong a cash position. Surprised it took as long as it did to see some of the sector gains biotech in general has seen especially after NIH made its vaccine position abundantly clear. $RARE is also inching up. Setrusumab is still an open question and is by no means guaranteed. However from a risk-reward perspective given downside is protected by the commercial business and has two other"  
[X Link](https://x.com/medstudentinvst/status/1978487036764934419) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-15T15:44Z XXX followers, XXX engagements


"October 16th 2025 Daily Update Markets go weeeeeeeeeeeeeeee portfolio comes back into the 70s after all but $RARE is red today. $RARE (and $PCVX to an extent) showed the most resilience. Again these are names that I think are likely to have high institutional interest and have not experienced the same run as some of the others. So not entirely surprised to see that"  
[X Link](https://x.com/medstudentinvst/status/1978918054227775740) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-16T20:16Z XXX followers, XXX engagements


"Totally agree DM1 is a huge market and $pepg very interesting. Re $WVE and INHBE may want to check out the attached post. I think there is a fairly high likelihood that $WVEs approach of further increasing adipocyte / hepatocyte lipolysis through INHBE silencing will worsen insulin sensitivity in patients who are already obese and almost certainly already have excess lipolysis as the baseline excess lipolysis is a major causal factor in insulin resistance / diabetes. I think there is a core difference in molecular profile between patients who have LoF INHBE gene variants and therein"  
[X Link](https://x.com/medstudentinvst/status/1979306544622895157) [@medstudentinvst](/creator/x/medstudentinvst) 2025-10-17T22:00Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@medstudentinvst Avatar @medstudentinvst WaveStrum Life Sciences

WaveStrum Life Sciences posts on X about $nktr, $vktx, $pepg, $rna the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX +94%

Mentions: X #

Mentions Line Chart

  • X Week XX -XXXX%
  • X Month XX +31%

Followers: XXX #

Followers Line Chart

  • X Week XXX +6.20%
  • X Month XXX +171%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence cryptocurrencies XXXXX% stocks XXXX% finance XXXX% currencies XXXX% countries XXXX%

Social topic influence $nktr 12.5%, $vktx 12.5%, $pepg 9.38%, $rna 9.38%, $beam 9.38%, $prme 9.38%, alltime 9.38%, $pcvx #1, $ntla 6.25%, bitcoin XXXX%

Top accounts mentioned or mentioned by @stocksdd @darrenestes @geneinvesting @adambliv @spcas9point5 @javier944712106 @pikabulb @andrews87261985

Top assets mentioned Viking Therapeutics, Inc (VKTX) Avidity Biosciences, Inc. Common Stock (RNA) BEAM (BEAM) Vaxcyte, Inc. Common Stock (PCVX) Intellia Therapeutics, Inc (NTLA) Bitcoin (BTC) Dyne Therapeutics, Inc. Common Stock (DYN) Janux Therapeutics, Inc. Common Stock (JANX) Public Service Enterprise Group, Inc. (PEG) Alnylam Pharmaceuticals, Inc. (ALNY) Sable Offshore Corp. (SOC) Thermo Fisher Scientific Inc. (TMO) SuperRare (RARE)

Top Social Posts #


Top posts by engagements in the last XX hours

"Hypothesis for a contributor to $PEPG s differentiated splicing improvement in DM1. $RNA and $DYN use DMPK1 RNA silencers which degrade and destroy the DMPK mRNA. In contrast $PEPG s ASO binds to the CUG repeats and sterically blocks the hairpin loop formation allowing the DMPK mRNA transcript to be translated normally. Most biological systems have negative feedback loops. So an increase in expression production or activity or a molecule will trigger inhibition of the expression production or activity of that molecule. Given $PEPG allows the DMPK mRNA to operate normally and produce the DMPK"
X Link @medstudentinvst 2025-10-04T08:55Z XXX followers, 1682 engagements

"October 10th 2025 Daily Update I allocated the remaining $RNA cash to $JANX today. If $NKTR continues to move down I will likely exit the tiny $BEAM and $VKTX holdings and put those towards $NKTR. Portfolio as a whole drew back about XXX% today largely driven by the top X positions in the portfolio ( $PRME $NTLA $PEPG). I expect $PRME and $PEPG to continue to experience significant volatility over the short to medium term and consider these price movements irrelevant unless my long-term thesis on the business changes or new data emerges. Though it means the portfolio as a whole is likely to"
X Link @medstudentinvst 2025-10-10T23:25Z XXX followers, 2486 engagements

"October 8th 2025 Daily Update All-time high. $NTLA and $PRME with big days. Though I would not be surprised to see continued volatility and a retraction. The gains for $NTLA are really little more than just noise until the data readouts in a few weeks. As mentioned in a previous post I exited $RNA at an effectively flat valuation. This is largely a function of believing there are biotech companies with similar risk profiles that have a higher upside rather than a negative view of $RNA. Certainly could be bought out and there is likely upside there. I initially entered $RNA as a relatively"
X Link @medstudentinvst 2025-10-08T20:16Z XXX followers, XXX engagements

"$ABVX didn't update again and just realized so here is the corrected daily update for $ABVX's actual close price. No change to headline total return"
X Link @medstudentinvst 2025-10-08T20:21Z XXX followers, XXX engagements

"Just closed small remaining positions in $VKTX and $BEAM. Proceeds went into $NKTR. Portfolio weights will be updated in daily update tonight"
X Link @medstudentinvst 2025-10-15T14:45Z XXX followers, XXX engagements

"Mostly just wanted to put the cash towards $NKTR. My view on $VKTX continue to be it likely has a market and upside if it maintains headline efficacy lead in the GLP-1 / GIP agonist class regardless of any side-effect incidence matched comparisons though competition from big players is intense and CMC remains important. I think it's likely continue to show in upcoming data readouts"
X Link @medstudentinvst 2025-10-15T14:53Z XXX followers, XXX engagements

"@AdamBLiv Alternatively you could just buy an asset that has a XXX% CAGR. Neither a 401k nor bitcoin necessary. I am the quant now"
X Link @medstudentinvst 2025-10-15T18:13Z XXX followers, XX engagements

"Alternatively you could just buy an asset that has a XXX% CAGR. Neither a 401k nor bitcoin necessary. I am the quant now"
X Link @medstudentinvst 2025-10-15T18:14Z XXX followers, XXX engagements

"Early Daily Update for posterity as I might never see this again and this whole thing could easily collapse tomorrow. The current portfolio is all green. The big glaring red mark is that dumb throwaway $MGX position I exited. The intrusive thoughts to re-enter and try and ride it until I erase that -XXXX% are flying simply fast and furious rn"
X Link @medstudentinvst 2025-10-15T19:15Z XXX followers, XXX engagements

"Wednesday October 15th 2025 Daily Update All-time high. Though always needs to be said this is a high risk portfolio and there are a number of upcoming events that could turn the ship right around. As mentioned closed the very small $BEAM and $VKTX positions today and put virtually all remaining cash into $NKTR"
X Link @medstudentinvst 2025-10-15T20:08Z XXX followers, 1016 engagements

"I have seen a number of posts questioning the safety of $PEPG's DM1 therapy based on previously published results for $PEPG's DMD therapy. I think there are a few misunderstandings regarding safety that are important to clear up. For background $PEG 's EDO-DM1 treats Myotonic Dystrophy Type X. EDO-51 treated DMD XX. These are two very different genetic diseases and both the structure and functional objective of each therapy's ASO is correspondingly very different. First $PEPG's EDO-51 DMD program was terminated by PEPGEN for efficacy not for safety. The mean increase in dystrophin expression"
X Link @medstudentinvst 2025-09-30T13:41Z XXX followers, 3633 engagements

"$ALNY has returned 76.5x since inception. $10000 invested at $X would be $766500 today. $50000 would be $3.83M today. $100000 would be $7.66M The picture attached is $ALNY 's stock chart. This represents the argument for why to stay long in the face of volatility when invested in early stage biotechnology companies which you believe have a very good chance of seeing enormous value accretion over the long-term based on TAM competitive differentiation current valuation etc. $ALNY 's share price saw significant volatility over the years. It collapsed soared plateaued and everything in between."
X Link @medstudentinvst 2025-10-07T22:12Z XXX followers, 1494 engagements

"Lorenzo "Botswana" (who has $1Bn of AUM a PhD XX other acronyms and clips $20M of annual management fees given he obviously is a X and XX guy minimum) shorted $SOC at $XX as announced after the fact. Word is he was also long $SPRB as announced the day after it increased XX trillion percent. Are there any investor materials available for a highly interested prospective LP such as myself"
X Link @medstudentinvst 2025-10-15T16:15Z XXX followers, 4624 engagements

"September 30th 2025 Daily Update This can't continue forever. but another all-time high today largely on the strength of $PRME. Good to see $PCVX back in the green too after announcing a $1Bn manufacturing deal with Thermo Fisher. My sense is $PCVX will be a beneficiary of a couple things: X. The market's realization that NIH / FDA isn't anti-vaccine it's anti-stupid vaccine. Or said more academically it's anti-vaccine for vaccines that have an unclear risk-reward tradeoff. In the United States pneumococcal pneumonia is estimated to result in approximately 150000 hospitalizations each year"
X Link @medstudentinvst 2025-09-30T23:52Z XXX followers, 1076 engagements

"$PCVX continues to inch-up. They still have data to show of course. However in my personal view it was an absolute steal a steal to be able to get this in the 30's for a company as large it is with such a strong a cash position. Surprised it took as long as it did to see some of the sector gains biotech in general has seen especially after NIH made its vaccine position abundantly clear. $RARE is also inching up. Setrusumab is still an open question and is by no means guaranteed. However from a risk-reward perspective given downside is protected by the commercial business and has two other"
X Link @medstudentinvst 2025-10-15T15:44Z XXX followers, XXX engagements

"October 16th 2025 Daily Update Markets go weeeeeeeeeeeeeeee portfolio comes back into the 70s after all but $RARE is red today. $RARE (and $PCVX to an extent) showed the most resilience. Again these are names that I think are likely to have high institutional interest and have not experienced the same run as some of the others. So not entirely surprised to see that"
X Link @medstudentinvst 2025-10-16T20:16Z XXX followers, XXX engagements

"Totally agree DM1 is a huge market and $pepg very interesting. Re $WVE and INHBE may want to check out the attached post. I think there is a fairly high likelihood that $WVEs approach of further increasing adipocyte / hepatocyte lipolysis through INHBE silencing will worsen insulin sensitivity in patients who are already obese and almost certainly already have excess lipolysis as the baseline excess lipolysis is a major causal factor in insulin resistance / diabetes. I think there is a core difference in molecular profile between patients who have LoF INHBE gene variants and therein"
X Link @medstudentinvst 2025-10-17T22:00Z XXX followers, XXX engagements

creator/x::medstudentinvst
/creator/x::medstudentinvst